SFSWAP | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
endothelial cell	18 studies	28% ± 12%	Explore
astrocyte	12 studies	29% ± 14%	Explore
natural killer cell	11 studies	20% ± 4%	Explore
oligodendrocyte precursor cell	11 studies	33% ± 15%	Explore
oligodendrocyte	11 studies	35% ± 13%	Explore
B cell	9 studies	23% ± 6%	Explore
naive B cell	9 studies	18% ± 3%	Explore
microglial cell	9 studies	28% ± 10%	Explore
fibroblast	9 studies	23% ± 7%	Explore
glutamatergic neuron	8 studies	37% ± 24%	Explore
T cell	7 studies	18% ± 2%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	7 studies	19% ± 4%	Explore
macrophage	7 studies	31% ± 8%	Explore
adipocyte	7 studies	24% ± 6%	Explore
GABAergic neuron	7 studies	34% ± 18%	Explore
plasmacytoid dendritic cell	7 studies	20% ± 5%	Explore
endothelial cell of lymphatic vessel	6 studies	27% ± 11%	Explore
CD16-positive, CD56-dim natural killer cell, human	6 studies	20% ± 3%	Explore
CD4-positive, alpha-beta T cell	6 studies	21% ± 7%	Explore
CD8-positive, alpha-beta T cell	6 studies	19% ± 5%	Explore
abnormal cell	6 studies	22% ± 9%	Explore
interneuron	6 studies	32% ± 21%	Explore
CD16-negative, CD56-bright natural killer cell, human	5 studies	19% ± 3%	Explore
effector memory CD8-positive, alpha-beta T cell	5 studies	20% ± 5%	Explore
neuron	5 studies	29% ± 13%	Explore
memory B cell	5 studies	17% ± 2%	Explore
epithelial cell	5 studies	38% ± 15%	Explore
ciliated cell	5 studies	23% ± 5%	Explore
basal cell	5 studies	29% ± 14%	Explore
type I pneumocyte	5 studies	20% ± 6%	Explore
pericyte	5 studies	23% ± 8%	Explore
smooth muscle cell	5 studies	18% ± 3%	Explore
gamma-delta T cell	5 studies	22% ± 9%	Explore
classical monocyte	4 studies	25% ± 8%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	4 studies	21% ± 5%	Explore
non-classical monocyte	4 studies	27% ± 10%	Explore
mature NK T cell	4 studies	18% ± 1%	Explore
myeloid cell	4 studies	22% ± 2%	Explore
dendritic cell	4 studies	31% ± 16%	Explore
lymphocyte	4 studies	28% ± 6%	Explore
regulatory T cell	4 studies	19% ± 3%	Explore
CD8-positive, alpha-beta memory T cell	4 studies	21% ± 2%	Explore
goblet cell	4 studies	30% ± 22%	Explore
leukocyte	3 studies	20% ± 4%	Explore
hematopoietic precursor cell	3 studies	25% ± 12%	Explore
glial cell	3 studies	24% ± 5%	Explore
granule cell	3 studies	20% ± 1%	Explore
mucosal invariant T cell	3 studies	17% ± 1%	Explore
retina horizontal cell	3 studies	18% ± 2%	Explore
myofibroblast cell	3 studies	22% ± 6%	Explore
monocyte	3 studies	22% ± 4%	Explore
transit amplifying cell	3 studies	32% ± 23%	Explore
mast cell	3 studies	20% ± 4%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
brain	15 studies	30% ± 19%	Explore
peripheral blood	6 studies	24% ± 8%	Explore
eye	4 studies	24% ± 12%	Explore
lung	3 studies	21% ± 3%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
adrenal gland	100%	3025.86	258 / 258	100%	15.52	230 / 230
bladder	100%	3985.29	21 / 21	100%	16.18	504 / 504
esophagus	100%	3827.79	1445 / 1445	100%	15.27	183 / 183
intestine	100%	4345.69	966 / 966	100%	13.60	527 / 527
pancreas	100%	2192.38	328 / 328	100%	14.64	178 / 178
prostate	100%	4384.69	245 / 245	100%	12.54	502 / 502
skin	100%	4909.35	1809 / 1809	100%	18.13	472 / 472
thymus	100%	4957.89	653 / 653	100%	15.52	605 / 605
uterus	100%	5257.06	170 / 170	100%	18.30	459 / 459
breast	100%	5038.58	459 / 459	100%	16.67	1117 / 1118
lung	100%	3795.85	578 / 578	100%	14.59	1152 / 1155
ovary	100%	5461.82	180 / 180	100%	13.62	428 / 430
brain	100%	3815.65	2636 / 2642	100%	20.21	703 / 705
stomach	100%	2921.42	359 / 359	99%	12.92	284 / 286
kidney	100%	3555.42	89 / 89	99%	13.60	894 / 901
liver	100%	1827.28	226 / 226	97%	8.84	394 / 406
adipose	100%	4665.91	1204 / 1204	0%	0	0 / 0
eye	0%	0	0 / 0	100%	16.35	80 / 80
lymph node	0%	0	0 / 0	100%	16.73	29 / 29
muscle	100%	2957.55	803 / 803	0%	0	0 / 0
spleen	100%	5090.27	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	16.03	45 / 45
ureter	0%	0	0 / 0	100%	13.94	1 / 1
blood vessel	100%	3859.96	1334 / 1335	0%	0	0 / 0
heart	99%	2125.08	854 / 861	0%	0	0 / 0
peripheral blood	97%	2317.73	899 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0000395	Biological process	mRNA 5'-splice site recognition
GO_0048025	Biological process	negative regulation of mRNA splicing, via spliceosome
GO_0000380	Biological process	alternative mRNA splicing, via spliceosome
GO_0005634	Cellular component	nucleus
GO_0005515	Molecular function	protein binding
GO_0003723	Molecular function	RNA binding

IV. Literature review

[source]

Gene name	SFSWAP
Protein name	Splicing factor, suppressor of white-apricot homolog (Splicing factor, arginine/serine-rich 8) (Suppressor of white apricot protein homolog) Splicing factor SWAP
Synonyms	SFRS8 SWAP
Description	FUNCTION: Plays a role as an alternative splicing regulator. Regulate its own expression at the level of RNA processing. Also regulates the splicing of fibronectin and CD45 genes. May act, at least in part, by interaction with other R/S-containing splicing factors. Represses the splicing of MAPT/Tau exon 10. .
Accessions	F5H1A5 ENST00000538548.5 ENST00000537164.1 ENST00000261674.9 [Q12872-1] ENST00000541286.5 [Q12872-2] H0YFR9 Q12872

SFSWAP report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review